Biliary Tract Malignancy: Improved Detection with Cytology and FISH Test [Featured Topic]

Mayo Clinic offers a test to assess for biliary tract malignancy through the combination of cytology and molecular testing by fluorescence in situ hybridization (FISH). This test is particularly useful when evaluating patients with primary sclerosing cholangitis (PSC) who are at high risk for developing cholangiocarcinoma.

View full content here.


Brent Westra

Brent Westra is a Marketing Segment Manager at Mayo Medical Laboratories. He leads marketing strategies for product management and specialty testing along with new media innovations. Brent has worked at Mayo Clinic since 2011.